![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Pharmaron Manufacturing Services (uk) Ltd. Cramlington Gb, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Flurbiprofen, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-270 - Rev 04
This Chemical Type CEP, issued on July 19, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1519 associated with this CEP further emphasizes